EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS)

Thierry Passeron, Jose Manuel Carrascosa, Richard B. Warren, Andreas Pinter, Marco Romanelli, Patricia Gorecki, Michela Efficace, Steve Fakharzadeh, Ya-Wen Yang, Ahlem Azzabi, Maria Jazra, Katya Lemos und 3 weitere

Dermatologic Therapy · 2023-01 · 2023 (1)

DOI: 10.1155/2023/9967747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatologic Therapy, 2023-11. Verfasst von Thierry Passeron und 14 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen-Cilag Ltd.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite the availability of effective biologic therapies for psoriasis, there is no gold‐standard treatment for nonpustular palmoplantar psoriasis (ppPsO).

Methods

G‐PLUS, a phase IIIb, double‐blind, placebo‐controlled, multicentre clinical trial, randomised adults with moderate‐to‐severe nonpustular ppPsO and limited plaque psoriasis (Psoriasis Area and Severity Index (PASI) ≥3 but

Förderung

  • Janssen-Cilag Ltd

Zitieren

APA

Passeron, T., Carrascosa, J. M., Warren, R. B., Pinter, A., Romanelli, M., Gorecki, P., Efficace, M., Fakharzadeh, S., Yang, Y., Azzabi, A., Jazra, M., Lemos, K., Leung, M., Chen, Y., & Thaçi, D. (2023). A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS). Dermatologic Therapy, 2023(1). https://doi.org/10.1155/2023/9967747

Vancouver

Passeron T, Carrascosa JM, Warren RB, Pinter A, Romanelli M, Gorecki P, et al. A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS). Dermatologic Therapy. 2023;2023(1). doi:10.1155/2023/9967747

BibTeX
@article{Passeron2023,
  author = {Passeron, Thierry and Carrascosa, Jose Manuel and Warren, Richard B. and Pinter, Andreas and Romanelli, Marco and Gorecki, Patricia and Efficace, Michela and Fakharzadeh, Steve and Yang, Ya-Wen and Azzabi, Ahlem and Jazra, Maria and Lemos, Katya and Leung, Monica and Chen, Yanqing and Thaçi, Diamant},
  title = {A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS)},
  journal = {Dermatologic Therapy},
  year = {2023},
  volume = {2023},
  number = {1},
  doi = {10.1155/2023/9967747}
}
Kostenlos starten →